NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
November 28, 2006 • Volume 3 / Number 46 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Cancer Stem Cells Detected in Colon Tumors

Director's Update
All Ireland-NCI Consortium Rolls On

Cancer Research Highlights
Eye-Sparing Method Effective for Ocular Melanoma Diagnosis

Nanoparticles Successfully Deliver Drugs to Brain Tumors in Mice

Risks Identified for New Solid Cancer after Stem Cell Transplants

Study Suggests Survival Benefit for Tamoxifen-Anastrozole Combo

FDA Update
FDA Expands Use of Herceptin for Early-Stage Breast Cancer After Primary Therapy

Spotlight
Giving Cancer an Energy Blackout

Featured Clinical Trial
Zactima for Recurrent or Progressive Brain Tumors

Notes
NIH Grants Must Be Submitted Electronically

AMA to Hold Meetings at Smoke-Free Sites

DNA Sequencing Centers to Examine Cancer

CCR Grand Rounds

Funding Opportunities

Community Update
End-of-Life Training Program on the Web is a Big Success

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Featured Article

Cancer Stem Cells Detected in Colon Tumors

Two teams of researchers have detected cancer stem cells in tumors from patients with colon cancer. When transplanted into mice, the cancer stem cells were able to form tumors that resembled the originals in patients, while most tumor cells could not.

Colon cancer is the latest type of cancer linked to these rare cells, which were first found in acute myeloid leukemia in 1994 and more recently in breast and brain tumors. The findings appeared online in two studies in Nature November 19. Read more  



Director's Update

All Ireland-NCI Consortium Rolls On

Approximately 2 years ago, in a special issue of the NCI Cancer Bulletin, there was a photo of Dr. Joe Harford, head of the NCI Office of International Affairs, with several dignitaries, holding a scale model of a new cancer research facility to be built in Belfast, Northern Ireland. About 2 weeks ago, I had the opportunity to tour the newly constructed facility, the Centre for Cancer Research and Cell Biology (CCRCB) on the campus of Queen's University Belfast.

The construction of this state-of-the-art facility, which is scheduled to be completely open early next year, could not have happened without the support of the Ireland-Northern Ireland-NCI Cancer Consortium, which is now entering its seventh year and is helping to transform cancer research and care across the island of Ireland. Read more  


The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov